Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users (Q34795051)

4 August 2017

1 reference

title

Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users (English)

1 reference

4 August 2017

1 reference

1 reference

1

Brian R Edlin

1 reference

4 August 2017

Marc N Gourevitch

5

0 references

author name string

Thomas F Kresina

2

1 reference

4 August 2017

Daniel B Raymond

3

1 reference

4 August 2017

Michael R Carden

4

1 reference

4 August 2017

Josiah D Rich

6

1 reference

4 August 2017

Laura W Cheever

7

1 reference

4 August 2017

Victoria A Cargill

8

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Clinical Infectious Diseases

4 August 2017

1 reference

4 August 2017

40 Suppl 5

1 reference

4 August 2017

S276-85

1 reference

Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Diagnosis, management, and treatment of hepatitis C

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

A syringe prescription program to prevent infectious disease and improve health of injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C and HIV infections: implications for clinical care in injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Antiretroviral adherence interventions: a review of current literature and ongoing studies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Response to treatment of hepatitis C in individuals with a recent history of intravenous drug abuse

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C virus infection: when silence is deception.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C and alcohol: interactions, outcomes, and implications

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C in the HIV-Infected Person

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Interventions to enhance patient adherence to medication prescriptions: scientific review.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Prevention and treatment of hepatitis C in injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Alcohol use and HIV pharmacotherapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C prevention programs: assessment of local health department capacity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Two successive hepatitis C virus infections in an intravenous drug user

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

The effect of syringe exchange use on high-risk injection drug users: a cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Drug abuse treatment as an HIV prevention strategy: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Risk factors among IDUs who give injections to or receive injections from other drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Prevalence and incidence of hepatitis C virus infection among young adult injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Brief intervention in a primary care setting for hazardous drinkers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

The role of the generalist in the care of the substance-abusing patient

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Harm reduction: a public health response to the AIDS epidemic among injecting drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Syringe and needle exchange as HIV/AIDS prevention for injection drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Medical care for injection-drug users with human immunodeficiency virus infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Management of occupational exposures to blood-borne viruses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Correlates of hepatitis C virus infections among injection drug users.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

HIV disease in the intravenous drug user: role of the primary care physician

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Primary care physicians and AIDS. Attitudinal and structural barriers to care

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment

8 July 2018

1 reference

Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco

21 January 2018

1 reference

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

21 January 2018

1 reference

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

21 January 2018

1 reference

Spectrum of disease in U.S. veteran patients with hepatitis C.

21 January 2018

1 reference

Provision of hepatitis C education in a nationwide sample of drug treatment programs

21 January 2018

1 reference

21 January 2018

1 reference

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

21 January 2018

1 reference

Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users

21 January 2018

1 reference

Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response

21 January 2018

1 reference

Alcohol potentiates hepatitis C virus replicon expression

21 January 2018

1 reference

Treatment of hepatitis C infection in injection drug users

21 January 2018

1 reference

Treating hepatitis C in methadone maintenance patients: an interim analysis

21 January 2018

1 reference

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

21 January 2018

1 reference

Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.

21 January 2018

1 reference

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

21 January 2018

1 reference

A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance

21 January 2018

1 reference

HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care

21 January 2018

1 reference

A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users

21 January 2018

1 reference

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

21 January 2018

1 reference

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

21 January 2018

1 reference

Psychiatric comorbidity in methadone maintained patients.

21 January 2018

1 reference

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

21 January 2018

1 reference

Care of patients with hepatitis C and HIV co-infection.

21 January 2018

1 reference

Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis B vaccination among high-risk adolescents and adults--San Diego, California, 1998-2001.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Helping the urban poor stay with antiretroviral HIV drug therapy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Syringe exchange and risk of infection with hepatitis B and C viruses

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1510897

Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room

26 October 2018

1 reference

Prevention and treatment of hepatitis C in injection drug users

21 January 2018

1 reference

Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws

21 January 2018

1 reference

12 December 2020

Effectiveness of interventions to improve patient compliance: a meta-analysis

1 reference

12 December 2020

Brief physician- and nurse practitioner-delivered counseling for high-risk drinkers: does it work?

1 reference

12 December 2020

Opportunities to address the hepatitis C epidemic in the correctional setting

1 reference

12 December 2020

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

12 December 2020

Potential of specialist drug services to deliver hepatitis B vaccination

1 reference

12 December 2020

Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination

1 reference

12 December 2020

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

1 reference

12 December 2020

Physician prescribing of sterile injection equipment to prevent HIV infection: time for action

1 reference

12 December 2020

Sharing of drug preparation equipment as a risk factor for hepatitis C

1 reference

12 December 2020

Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif

1 reference

12 December 2020

Hepatitis C and alcohol

1 reference

12 December 2020

1 reference

12 December 2020

NIH Consensus Statement on Management of Hepatitis C: 2002

1 reference

12 December 2020

Protection against viral hepatitis. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Screening for problem drinking and counseling by the primary care physician-nurse team

1 reference

12 December 2020

Caring for "socially undesirable" patients

1 reference

12 December 2020

Interventions to prevent HIV risk behaviors

1 reference

12 December 2020

Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study

1 reference

12 December 2020

Hepatitis C screening and management practices: a survey of drug treatment and syringe exchange programs in New York City

1 reference

12 December 2020

Identifiers

DOI

10.1086/427441

1 reference

4 August 2017

1 reference

4 August 2017

1 reference